News

Ten years on, Lung-MAP success demonstrates potential of public-private partnerships in clinical research

RNA-based molecular subtypes modestly improved predictions for pathologic downstaging in muscle-invasive bladder cancer.

Results of large pragmatic trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

Nivolumab added to AVD chemotherapy expected to become new standard for initial treatment for advanced stage disease in adolescents and adults, based on trial data to be presented at 2023 ASCO Annual Meeting plenary session

Results of SWOG S1929 trial show patients with small-cell lung cancer with SLFN11 expression can benefit from PARP inhibitor added to immune checkpoint blockade

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors